By conducting a clinical utility study for Proteomics International’s PromarkerD (a blood-based test that predicts the risk of kidney disease/decline in Type 2 diabetes patients), Veranex provided evidence of the test’s value to physicians and its...
Read More
Veranex’s Commercial Strategy and Market Access team members, Manasi Datar, PhD, Li-Chen Pan, MPH, and Thomas F. Goss, PharmD, along with members...
1 min read
WHAT DOES THIS MEAN? Monkeypox virus is a zoonotic infection, caused by Orthopoxvirus genus of the Poxviridae family like variola virus (the...
2 min read
The Chinese government has implemented a series of efforts to improve access to novel oncology therapies, one example of this is the significant...
10 min read
Akhil Saklecha MD, Managing Director, Ventures Jihad Kaouk MD, Director, Center for Laparoscopic & Robotic Surgery, Cleveland Clinic A leader in...
In this article written by our software regulatory team, we explore how machine learning intersects with medical device development and how the...
YOU BE THE ANATOMIST! What important anatomical structure has been highlighted here, and employing what imaging modality? ANSWER The left atrial...
5 min read
Paul LaViolette Managing Partner & COO, SV Health Investors Forging where others are tentative to trod, SV Health Investors, in partnership with...
We welcome you to Annapolis, MD for the conference Biocompatibility Insights 2023. Biocompatibility Insights is a conference focusing solely on...
